About SNIPR Biome
SNIPR Biome is a company based in Copenhagen (Denmark) founded in 2011 by Morten O A Sommer, Jasper Clube, and Christian Groendahl.. SNIPR Biome has raised $139.02 million across 8 funding rounds from investors including European Investment Bank, Cystic Fibrosis Foundation and Life Sciences Partners. The company has 43 employees as of December 31, 2023. SNIPR Biome offers products and services including CRISPR Microbial Therapy and Microbiome Pipeline. SNIPR Biome operates in a competitive market with competitors including Cepheid, Day Zero Diagnostics, SeLux Diagnostics, SpinDiag and Specific Technologies, among others.
- Headquarter Copenhagen, Denmark
- Employees 43 as on 31 Dec, 2023
- Founders Morten O A Sommer, Jasper Clube, Christian Groendahl
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
$-13.28 M (USD)17as on Dec 31, 2023
-
EBITDA
$-14.49 M (USD)16as on Dec 31, 2023
-
Total Equity Funding
$139.02 M (USD)
in 8 rounds
-
Latest Funding Round
$40.64 M (USD), Series B
Aug 07, 2025
-
Investors
European Investment Bank
& 6 more
-
Employee Count
43
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SNIPR Biome
SNIPR Biome offers a comprehensive portfolio of products and services, including CRISPR Microbial Therapy and Microbiome Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for engineering microbiomes to treat bacterial diseases.
System for advancing CRISPR treatments to clinical trials.
Unlock access to complete
Unlock access to complete
Funding Insights of SNIPR Biome
SNIPR Biome has successfully raised a total of $139.02M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $40.64 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series B — $40.6M
-
First Round
First Round
(01 Jun 2017)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series B - SNIPR Biome | Valuation |
investors |
|
| Dec, 2024 | Amount | Debt – Venture - SNIPR Biome | Valuation |
investors |
|
| Jan, 2024 | Amount | Series B - SNIPR Biome | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SNIPR Biome
SNIPR Biome has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank, Cystic Fibrosis Foundation and Life Sciences Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science companies are funded through venture capital investments.
|
Founded Year | Domain | Location | |
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location | |
|
Investments are made in early-stage healthcare startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SNIPR Biome
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SNIPR Biome
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Snipr Biome Comparisons
Competitors of SNIPR Biome
SNIPR Biome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Day Zero Diagnostics, SeLux Diagnostics, SpinDiag and Specific Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of molecular diagnostic testing solutions
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of alternatives to traditional ELISA assays
|
|
| domain | founded_year | HQ Location |
Point-of-care systems for screening drug-resistant pathogens are developed.
|
|
| domain | founded_year | HQ Location |
Detection and antibiotic susceptibility testing for blood infections are provided.
|
|
| domain | founded_year | HQ Location |
Protein expression platform development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Snipr Biome
Frequently Asked Questions about SNIPR Biome
When was SNIPR Biome founded?
SNIPR Biome was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Where is SNIPR Biome located?
SNIPR Biome is headquartered in Copenhagen, Denmark.
Who is the current CEO of SNIPR Biome?
Christian Groendahl is the current CEO of SNIPR Biome. They have also founded this company.
Is SNIPR Biome a funded company?
SNIPR Biome is a funded company, having raised a total of $139.02M across 8 funding rounds to date. The company's 1st funding round was a Series B of $11.89M, raised on Jun 01, 2017.
How many employees does SNIPR Biome have?
As of Dec 31, 2023, the latest employee count at SNIPR Biome is 43.
What does SNIPR Biome do?
SNIPR Biome was founded in 2011 in Copenhagen, Denmark, within the biotechnology sector. Microbiome-based treatments for infectious diseases are offered through CRISPR technology that targets microorganisms and resists foreign genetic elements. Drug candidates based on bacterial Cas nuclease activity are developed for conditions including inflammatory bowel disease, multi-drug resistant infections, and cancer. Operations focus on therapeutic applications in human health.
Who are the top competitors of SNIPR Biome?
SNIPR Biome's top competitors include Cepheid, Day Zero Diagnostics and ExpressionEdits.
What products or services does SNIPR Biome offer?
SNIPR Biome offers CRISPR Microbial Therapy and Microbiome Pipeline.
Who are SNIPR Biome's investors?
SNIPR Biome has 7 investors. Key investors include European Investment Bank, Cystic Fibrosis Foundation, Life Sciences Partners, Lundbeck Foundation, and Wellington Partners Venture Capital.
What is SNIPR Biome's valuation?
The valuation of SNIPR Biome is $74.1M as of Jan 2024.